The Scale, Causes and Costs of Medicines Waste – a national perspective Northamptonshire Medicine Waste Management Conference, 28 th November 2012 David.

Slides:



Advertisements
Similar presentations
Community Pharmacy – Call to Action Derbyshire / Nottinghamshire Area Team.
Advertisements

Medicines Management Waste Campaign 2014 Jennifer Bartlett – Senior Medicines Management Adviser Nicola Swindell – Medicines Management Team Co-ordinator.
Mike Keen, CEO, Kent LPC. Why is change needed? NHS England states that: Primary care services face increasingly unsustainable pressures Community pharmacy.
Primary Health Care Reform in Australia National Health and Hospital Reform Commission Professor Justin Beilby University of Adelaide.
Title: PEOPLE LIVING WITH HIV/AIDSIN EGYPT: ROLE OF COMMUNITY PHARMACIST Authors: Nahla Maher Hegab Pharmacy graduate. Institution: College of pharmacy,
Walsall Medicines Waste Walsall Medicines Management Team.
The challenge of medicines non-adherence. 2 How is adherence defined? WHO definition: ‘the extent to which a person’s behaviour – taking medication, following.
NPS is an independent, non-profit organisation for Quality Use of Medicines, funded by the Australian Government Department of Health and Ageing. Safe.
The Challenges for Medicines Optimisation
Questions or comments on this presentation can be addressed to You can pick and choose the elements.
Managing Medicines Use by PBC Groups in West Hertfordshire Dr Alison Davies.
Improving prescribing quality Richard Seal Programme Director National collaborative medicines management services programme.
1 “Medicines use review conducted in community pharmacy" Professor Ian Chi Kei Wong Department of Health Public Health Career Scientist The School of Pharmacy.
OPTIMISING MEDICINES USE GRAHAM DAVIES Professor of Clinical Pharmacy & Therapeutics Institute of Pharmaceutical Science King’s College London.
Two Goals of Today’s Talk 1.Review some research on the value of increased longevity 2.Link the results of that research to important policy questions.
Investments in HIV and AIDS are paying off by reducing incidence and mortality Carlos Avila, MD, ScD. Abt Associates, Washington DC Melbourne 22 July 2014.
Think Pharmacy Sue Sharpe CEO PSNC. Outline of Talk The Vision for the future community pharmacy The four domains for pharmacy services  Medicines Optimisation.
Clinical Pharmacy Basma Y. Kentab MSc..
Strengthening partnerships: A National Voluntary Health Agency’s initiatives in managed care Sarah L. Sampsel, MPH* Lisa M. Carlson, MPH, CHES* Michele.
1.Define marketing and describe its contributions. 2. Differentiate among the concepts of needs, wants, and demands. 3. Define the concept of exchange.
Pharmacy Administration By Dr. Shaimaa Mahmoud Nashat Canadian equivalent Master Degree in Clinical Pharmacy - Toronto University – Canada Canadian Board.
NHS Rushcliffe Clinical Commissioning Group (CCG).
Prevention for older people: context, policy and economics Julien Forder.
Learn more about ways to Bend the Curve in health care costs at: Made possible through support from: Preventing Hospital Readmissions:
Pharmaceutical Economics Heng-Sim Lee RPh MS Director of Pharmacy, ChiaYi Branch, Taichung Veterans General Hospital Clinical Nutritional.
Septamber The purpose of imposing sanctions on the target country is to force it’s government to respect human rights, but sometimes they themselves.
New Zealand – Can we live up to the ‘clean-green’ image? Dr Rhiannon Braund School of Pharmacy University of Otago New Zealand.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
TORFAEN MEDICATION ADMINISTRATION SCHEME Val Bessell Wendy Tyler-Batt.
Climate Change, Health and Communities: New times, New challenges Chris Church Community Environment Associates March 2013.
Healthy Living and Diabetes workshop. Content of the workshop Introduction to chronic non-communicable diseases and IPSF activities in the past on that.
Every Child Matters Pamela Graham November Objectives for this session: To offer an historical perspective on the development of services for children.
6th Annual Future of the Pharmaceutical Benefits Scheme Friday 1st May 2009, Sydney Realising the impact of the PBS reforms on consumer demand for medicines.
© Nuffield Trust 24 October 2015 NHS payment reform: evolving policy and emerging evidence Chief Economist: Anita Charlesworth.
Falls prevention in care homes and at home Dr Raymond F Jankowski.
“Fit for Work Ireland” The Institute of Physical Therapy & Applied Science Croke Park April 2014 John Church – CEO, Arthritis Ireland.
Improving the effectiveness of integrated care teams Rob Darracott Pharmacy Voice.
Market and Command Economies
Cancer Mortality Target Measuring and Monitoring at a National Level Jennifer Benjamin, Department of Health Kathy Elliott, National Cancer Action Team.
Zokufa HZ, Pillay T Pharmaceutical Policy and Planning National Department of Health- South Africa.
Community Pharmacy Cheshire & Wirral (CPCW) Helen Murphy Chief Executive Officer Community Pharmacy Cheshire and Wirral.
BY. ASHLEY MCLAUGHLIN TOPICS IN PHYSICAL THERAPY I SPRING 2015 Mental Health Promotion.
Five Year Forward View: Personal Health Budgets and Integrated Personal Commissioning Jess Harris January 2016.
Community Pharmacy in 2016 and beyond: A summary of the Pharmacy Voice response Nanette Kerr Chief Executive Officer Company Chemists’ Association A member.
Putting Patients at the Centre of Care What can my Community Pharmacist do for me? Dr Tarlochan Gill Chairman, Kent & Medway Pharmacy Local Professional.
Community Pharmacy in 2016 and beyond: A summary of the Pharmacy Voice response Elizabeth Wade Director of Policy, Pharmacy Voice April 2016 Slide 1 of.
Educational solutions for the NHS pharmacy workforce Medicines Optimisation: Helping patients to make the most of medicines Sue Carter Regional Tutor
MTM Medication Therapy Management. What is Medication Therapy Management? From 1996 to 2006, the number of prescription medications dispensed increased.
The Medicines Adherence and Waste Challenge Carol Roberts Director of Strategic Prescribing EAHSN and PrescQIPP.
Think Pharmacy Sue Sharpe CEO PSNC. Outline of Talk The Vision for the future community pharmacy The four domains for pharmacy services  Medicines Optimisation.
Given the progress that continues to be made in society’s battle against disease, patients are seeking more information about medical problems and potential.
Medicines adherence Implementing NICE guidance 2009 NICE clinical guideline 76.
Introduction 2. Pharmaceutical care is a professional patient care practice, which, when provided as an organized service, is experienced, documented,
Safety in Medicines: Raising the profile with the Royal Pharmaceutical Society Liz Rawlins Communications Officer 9 May 2011.
European Community Pharmacy Blueprint A perspective from general practice Professor Tony Avery.
Pharmacy White Paper Building on Strengths Delivering the Future Overview.
Approaches used in Health Promotion Campaigns. Choice and Justification of Approaches Level of Achievement 4: Research and make a detailed analysis of.
An Economic Perspective
Presentation for Healthcare Professionals
Think Pharmacy Sue Sharpe CEO PSNC.
Integrating Clinical Pharmacy into a wider health economy
Somerset Together David Slack, Managing Director
Conference on noise 24 April 2017 John F Ryan Director public health.
Implications Rural health disparities are present in a variety of ways: educationally, socially, economically, etc. With attention to these obstacles.
Turning the Tide in Health Care Starts with Chronic Disease
Victoria Gemmell1 Professor Alex Mullen2
Medicines Safety Programme
Community Pharmacy: your local healthcare team
Point of Dispensing and Counselling Intervention Enhanced Service: Community Pharmacy (PODIS)
Pharmacy Integration Improving care in care homes
Presentation transcript:

The Scale, Causes and Costs of Medicines Waste – a national perspective Northamptonshire Medicine Waste Management Conference, 28 th November 2012 David Taylor Professor of Pharmaceutical and Public Health Policy The UCL School of Pharmacy

Northamptonshire Medicine Waste Management Conference This presentation Offers some initial thoughts about waste in general and medicines waste in particular Summarises the main findings of the YHEC/SoP report on medicines wastage Discusses some suggestions relating to medicines use optimisation and waste minimisation, in the light of the current reform process

Northamptonshire Medicine Waste Management Conference Waste can be measured physically (as in tons discarded) or in terms of lost opportunity (such as years of life not saved or disability not prevented) It can also be measured in terms of sum of the prices of the items discarded. But this can be a misleading approach

Northamptonshire Medicine Waste Management Conference Pharmaceuticals as special goods? Medicines typically have high fixed (sunk) costs of development and relatively low marginal costs of production All medicines are potential poisons which if used carefully bestow benefits. But this is true of many other things Waste is common in societies like ours. For example, between 10 and 20 per cent of all food purchased is thrown away

Northamptonshire Medicine Waste Management Conference Professionals as special people? Professions were historically trades that needed special regulation and management because of their special knowledge The danger of believing naively in the value of professionalism is that we may come to judge all non- professional people as lacking ‘our abilities’ ‘What is not paid for is not valued’ (?)

Northamptonshire Medicine Waste Management Conference, The overall cost of NHS medicines wastage in the English community setting We found the gross annual ‘cost’ of NHS primary care material medicines wastage in England to be about £300 million pa in 1979, or £1 in every £25 devoted to pharmaceutical purchasing Of this £110 million was accounted for by pharmacy returns and £50 million by care home waste The estimated therapeutic opportunity cost of not taking or under-using medicines in just five therapeutic areas was put at £500 million

Northamptonshire Medicine Waste Management Conference Research limitations A degree of over- or under-estimation may have occurred. But the available evidence indicates since the 1990s medicines wastage has almost certainly fallen relative to the volume of prescribing

Northamptonshire Medicine Waste Management Conference There is no evidence that the NHS has a special systemic problem in managing medicines waste, as compared with that observed in other countries and systems The level of medicines wastage that is cost effectively preventable is in the order of 50% of the total recorded, or £3 million per million population minus additional intervention costs. It deserves serious attention. But any such savings should be seen in the light of annual NHS spending of some £120 billion a year in England alone

Northamptonshire Medicine Waste Management Conference. The causes of medicines waste in the community setting Recovery before dispensed medicines are all used Side effects leading to a change in therapy Disease progression Death or admission to institutional care Inappropriate prescribing and/or dispensing Care system failures, people’s fears and uncertainties Deliberate or accidental patient non-adherence Rob Horne

Northamptonshire Medicine Waste Management Conference Opportunities for further performance improvement include.... Better support for patients around the time of initial supply (see now the NMS) Enhanced prescribing and case management (targeted MURs?) Incentivising better professional supervision at the point of dispensing Informed and flexible use of 28 day prescribing Better (pharmaceutical) care for vulnerable in the community setting Better integrated and managed end of life care Communicating the links between better health outcomes, medicines waste reduction and overall economic efficiency and service quality

Northamptonshire Medicine Waste Management Conference Controversies include.... Poor world health needs – should we give unused medicines to communities in need of aid? Can ‘DUMP’ campaigns be counter-productive? Is nursing/care home medicines wastage something we should not be worried about? Does paying for your medicines make you feel more entitled to waste them? Do discarded medicines cause significant environmental damage?

Northamptonshire Medicine Waste Management Conference Conclusions and recommendations Care for people you work with, but do not waste labour Creating value in health care involves respecting consumer preferences, not just meeting their professionally defined needs As with any type of risk or unwanted event, reducing medicines waste is normally desirable. But it is not worth achieving any cost

Northamptonshire Medicine Waste Management Conference There is good reason to value what pharmacists and other colleagues have achieved in areas such as NHS medicines cost control and waste reduction over the past decade. Those responsible for managing the transition to CCGs and the NHSCB should be careful not to under- estimate what has been done. In looking to the future it will be important to put achieving better health and social outcomes and promoting goals like healthy ageing first. Medicines waste is best seen as an indicator of poor care and lost opportunity for greater wellbeing, rather than as a major concern in its own right.

Northamptonshire Medicine Waste Management Conference ucl.ac.uk